Hepatocellular Cancer Terminated Phase 1 Trials for Pazopanib (DB06589)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01012362Study of Pazopanib and Ixabepilone in Patients With Solid TumorsTreatment